hotspot -WSS

hotspot

author：leisure time 2025-10-04 03:59:22 - browse：744

Perrigo Opill press photo – pharma coverage from STAT — Opill, the first over-the-counter birth control pill, is on its way to U.S. stores. Perrigo via AP

WASHINGTON — The first over-the-counter birth control pill will be available in U.S. stores later this month, allowing American women and teens to purchase contraceptive medication as easily as they buy aspirin.

Manufacturer Perrigo said Monday it has begun shipping the medication, Opill, to major retailers and pharmacies. A one-month supply will cost about $20 and a three-month supply will cost around $50, according to the company’s suggested retail price. It will also be sold online.

The launch has been closely watched since last July, when the Food and Drug Administration said the once-a-day Opill could be sold without a prescription. Ireland-based Perrigo noted there will be no age restrictions on sales, similar to other over-the-counter medications.

Opill is an older class of contraceptive, sometimes called minipills, that contain a single synthetic hormone, progestin, and generally carry fewer side effects than more popular combination estrogen and progestin pills.

Newsletters

Sign up for Morning Rounds

Understand how science, health policy, and medicine shape the world every day

Please enter a valid email address. Privacy Policy

The launch gives U.S. women another birth control option amid the legal and political battles over reproductive health, including the reversal of Roe v. Wade, which has upended abortion access across the U.S. Opill’s approval is unrelated to the ongoing court battles over the abortion pill mifepristone. And anti-abortion groups have generally emphasized that they do not oppose contraceptives to prevent pregnancies.

Birth control pills are available without a prescription across much of South America, Asia, and Africa.

The drug’s approval came despite some concerns by FDA scientists about the company’s results, including whether women with certain medical conditions would understand that they shouldn’t take the drug.

Dr. Verda Hicks, president of the American College of Obstetricians and Gynecologists, in a statement, said studies have shown that patients, including adolescents, can effectively screen themselves to use the pills.

— Matthew Perrone

Previous article： How to save PrEP access — and even expand it
Next article： Sanofi strikes deal with Novavax, boosting the vaccine maker

WSS

What nurses really want: sufficient staffing for patient care

Elevance, private equity launch primary care company

Bird flu outbreak in cows is latest avian flu curveball

Key lawmaker blasts Congress’ efforts on addiction: ‘Shame on us’

First recipient of genetically engineered pig kidney has died

DeSantis talks Trump, trans issues and 'what wokeness is'

Wikipedia

hotspot

Sign up for Morning Rounds

entertainment

The high cost of giving birth even with insurance

After gene therapy, two congenitally deaf children hear for the first time

Hollywood unions extend contract negotiations for actors

Study: AI not yet building 'n

State Dept. review finds Biden bears some blame for Afghanistan failures

Judge rejects Trump's request to move Stormy Daniels hush

BioMarin wins approval for gene therapy to treat hemophilia A

Affordable Connectivity Program vital to health care, experts say

Malaria cases in Florida and Texas: Here’s what you need to know

7 more heat

Wikipedia

Sanofi strikes deal with Novavax, boosting the vaccine maker

Driven by the pandemic, applicants flood public health schools

Wildfires rage amid heat wave in Greece, prompting evacuations and call for European support

'Stay indoors': Escaped wild animal on the loose in Berlin prompts urgent citywide search

H5N1 communication has been strictly for the birds

Software glitch causes Tandem insulin pump to shutdown, FDA warns

Wikipedia

explore

hotspot

focus